An Oxford University spinout company is developing a molecular superglue for the rapid development of vaccines targeting a range of diseases. SpyBiotech, co-founded by Jenner researchers Sumi Biswas, Jing Jin and Simon Draper aims to facilitate the rapid development of robust and novel vaccines.
The tenth anniversary of the European Research Council (ERC) has been marked by a series of events and a video featuring some of Oxford's recipients of ERC funding. In a video to mark the anniversary, a number of Oxford University academics have explained how ERC funding has been vital to their research, including Adrian Hill, Director of the Jenner Institute.
Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models. Sci Rep, 7, pp. 46482. Article
Leukocyte counts and lymphocyte subsets in relation to pregnancy and HIV infection in Malawian women. Am J Reprod Immunol. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Prof Sarah Cleaveland: One Health in Tanzania: interventions, insights and impacts, 02/May/2017 14:00